Zidovudine Main Page

Medical Advocates
Zidovudine (Retrovir)

Main Page

New and Noteworthy
Retrovir PI
FDA Updates
Database of ARV Drug Interactions
Guidelines
Combivir Data
Journal Data
Conference Data
Perinatal Data
Pediatric Data

ARV Drugs Main Page Main New/Newsworthy Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: February 27, 2010

Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

February 2010

17th CROI Citations

POSTER
IL-10-1082-G/A Promoter Variant Alters HIV-1 Mother-to-Child-Transmission in African
Mother-Infant Pairs Exposed to Zidovudine at Delivery
J Wong, P Ruan, Kumud Singh, et al
PDF Poster Abstract

POSTER
Impact of HAART and Short-course Zidovudine on Longitudinal Growth of HIV-exposed
Uninfected Breastfed Infants, Botswana
K Powis, L Smeaton, A Ogwu, et al
PDF Poster Abstract

Impact of Zidovudine on Hematologic Parameters during Treatment with Peginterferon alfa-2a
plus Ribavirin for Chronic Hepatitis C in HIV/HCV Co-infected Patients Enrolled in a Large
Randomized Double-blind Study
M Rodriguez-Torres, Jihad Slim, L Bhatti, et al

Journal Citations

Antiviral Activity of Zidovudine and Tenofovir in the Presence of the K65R Mutation
in Reverse Transcriptase: An International Cohort Analysis.
Grant PM, Taylor J, Nevins AB, et al Antimicrob Agents Chemother. 2010 Feb 1.

Durability of initial antiretroviral therapy in a resource-constrained setting and the
potential need for Zidovudine weight-based dosing.
Willig JH, Echevarria J, Westfall AO, et alJ Acquir Immune Defic Syndr. 2010 Feb 1;53(2):215-21.

ARV Drugs Main Page Main New/Newsworthy Home Page

Zidovudine Main Page

I